Kilitch Drugs (India) Limited

Informe acción NSEI:KILITCH

Capitalización de mercado: ₹5.0b

Kilitch Drugs (India) Dividendos y recompras

Dividendo controles de criterios 0/6

Kilitch Drugs (India) no paga actualmente dividendo.

Información clave

0%

Rentabilidad por dividendo

0%

Rendimiento de la recompra

Rendimiento total para el accionista0%
Rendimiento futuro de los dividendosn/a
Crecimiento de los dividendosn/a
Próxima fecha de pago de dividendosn/a
Fecha ex dividendon/a
Dividendo por acción₹0.500
Ratio de pago0%

Últimas actualizaciones de dividendos y recompras

No hay actualizaciones

Recent updates

Kilitch Drugs (India) Limited (NSE:KILITCH) Not Flying Under The Radar

Jul 23
Kilitch Drugs (India) Limited (NSE:KILITCH) Not Flying Under The Radar

Here's Why Kilitch Drugs (India) (NSE:KILITCH) Can Manage Its Debt Responsibly

Mar 05
Here's Why Kilitch Drugs (India) (NSE:KILITCH) Can Manage Its Debt Responsibly

Kilitch Drugs (India) Limited (NSE:KILITCH) Looks Just Right With A 26% Price Jump

Feb 02
Kilitch Drugs (India) Limited (NSE:KILITCH) Looks Just Right With A 26% Price Jump

We Ran A Stock Scan For Earnings Growth And Kilitch Drugs (India) (NSE:KILITCH) Passed With Ease

Jan 30
We Ran A Stock Scan For Earnings Growth And Kilitch Drugs (India) (NSE:KILITCH) Passed With Ease

Investors Shouldn't Be Too Comfortable With Kilitch Drugs (India)'s (NSE:KILITCH) Earnings

Nov 17
Investors Shouldn't Be Too Comfortable With Kilitch Drugs (India)'s (NSE:KILITCH) Earnings

Shareholders Would Not Be Objecting To Kilitch Drugs (India) Limited's (NSE:KILITCH) CEO Compensation And Here's Why

Sep 23
Shareholders Would Not Be Objecting To Kilitch Drugs (India) Limited's (NSE:KILITCH) CEO Compensation And Here's Why

These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well

Sep 08
These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well

Here's Why Kilitch Drugs (India) (NSE:KILITCH) Has Caught The Eye Of Investors

May 05
Here's Why Kilitch Drugs (India) (NSE:KILITCH) Has Caught The Eye Of Investors

Kilitch Drugs (India) (NSE:KILITCH) Could Easily Take On More Debt

Jul 06
Kilitch Drugs (India) (NSE:KILITCH) Could Easily Take On More Debt

Here's Why I Think Kilitch Drugs (India) (NSE:KILITCH) Might Deserve Your Attention Today

Apr 08
Here's Why I Think Kilitch Drugs (India) (NSE:KILITCH) Might Deserve Your Attention Today

These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well

Dec 17
These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well

Is Kilitch Drugs (India) (NSE:KILITCH) Using Too Much Debt?

Mar 21
Is Kilitch Drugs (India) (NSE:KILITCH) Using Too Much Debt?

Should Weakness in Kilitch Drugs (India) Limited's (NSE:KILITCH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Feb 13
Should Weakness in Kilitch Drugs (India) Limited's (NSE:KILITCH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Is Kilitch Drugs (India) (NSE:KILITCH) Weighed On By Its Debt Load?

Dec 03
Is Kilitch Drugs (India) (NSE:KILITCH) Weighed On By Its Debt Load?

Does Kilitch Drugs (India) Limited (NSE:KILITCH) Have A Place In Your Dividend Stock Portfolio?

Aug 20
Does Kilitch Drugs (India) Limited (NSE:KILITCH) Have A Place In Your Dividend Stock Portfolio?

Should Weakness in Kilitch Drugs (India) Limited's (NSE:KILITCH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Jul 16
Should Weakness in Kilitch Drugs (India) Limited's (NSE:KILITCH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: No hay datos suficientes para determinar si los dividendos por acción de KILITCH han sido estables en el pasado.

Dividendo creciente: Datos insuficientes para determinar si los pagos de dividendos de KILITCH han aumentado.


Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de Kilitch Drugs (India) vs. Mercado
¿Cómo se compara la rentabilidad por dividendo de KILITCH con la del mercado?
SegmentoRentabilidad por dividendo
Empresa (KILITCH)0%
Suelo de mercado 25% (IN)0.3%
Techo de mercado 25% (IN)1.2%
Media de la industria (Pharmaceuticals)0.7%
Analista de previsiones (KILITCH) (hasta 3 años)n/a

Dividendo destacado: No es posible evaluar la rentabilidad por dividendo de KILITCH en comparación con el 25% inferior de los pagadores de dividendos, ya que la empresa no ha comunicado ningún pago reciente.

Alto dividendo: No es posible evaluar la rentabilidad por dividendo de KILITCH en comparación con el 25% de los principales pagadores de dividendos, ya que la empresa no ha comunicado ningún pago reciente.


Pago de beneficios a los accionistas

Cobertura de los beneficios: KILITCH no paga un dividendo notable para el mercado Indian.


Pago en efectivo a los accionistas

Cobertura de flujo de caja: No es posible calcular la sostenibilidad de los dividendos, ya que KILITCH no ha comunicado ningún pago.


Descubre empresas que pagan buenos dividendos